Abstract: A drug delivery device for placement in the eye includes a drug core comprising a pharmaceutically active agent, and a holder that holds the drug core. The holder is made of a material impermeable to passage of the active agent and includes an opening for passage of the pharmaceutically agent therethrough to eye tissue. The device includes a layer of material permeable to passage of the active agent. The material permeable to passage of the active agent has a degree of crystallinity selected to influence the release kinetics.

Abstract: The present invention is a process for making a plurality of drug delivery devices for ocular delivery. The plurality of drug delivery devices are made in part of poly(vinyl alcohol). During the manufacturing process the poly(vinyl alcohol) is cured. The poly(vinyl alcohol) may be in the form of separate pieces, a unitary sheet or may be incorporated into the drug delivery device at the time of curing. During the step of curing the humidity is controlled to ensure improved consistency during the curing process. The improved consistency results in inventories of drug delivery devices that have different cure times.

Abstract: The present invention is a process for making a plurality of drug delivery devices for implantation in the eye of a patient. The plurality of drug delivery devices are made in part of poly(vinyl alcohol). During the manufacturing process the poly(vinyl alcohol) is cured. The poly(vinyl alcohol) may be in the form of separate pieces, a unitary sheet or may be incorporated into the drug delivery device at the time of curing. During the step of curing the humidity is controlled to ensure improved consistency during the curing process. The improved consistency results in inventories of drug delivery devices that have different cure times.

Abstract: Methods for enhancing biocidal efficacies and product stability of lens care solutions comprising packaging such solutions in containers fabricated from poly(ethylene terephalate).